The Committee on Biologics and Regenerative Medicine serves the Academy and the public by reviewing and monitoring scientific and regulatory developments in the field of implantable biologicals, tissue components, and combination biological/biomedical device products as they relate to orthopaedic surgery, care, and practice. The Biological Implants Committee interacts with governmental, regulatory, and standard-setting organizations, as well as orthopaedic device manufacturers to promote the promulgation of safe and efficacious biological products for use in orthopaedics.
